Results 21 to 30 of about 3,364,808 (342)
Clozapine in severe psychotic disorders: Balancing safety with efficacy
European Psychiatry, 2021 Introduction Clozapine is a member of the dibenazepine class of antipsychotic drugs and has been designated an atypical antipsychotic drug. Clinical studies have shown that clozapine is effective in ameliorating the core symptoms, as well as the ...
R. Almeida Leite +3 more
doaj +1 more source
Pancreatitis following Olanzapine Therapy: A Report of Three Cases [PDF]
, 2007 CONTEXT: Atypical antipsychotic agents (clozapine, olanzapine) have been linked to metabolic effects and acute pancreatitis. CASE REPORT: We reviewed the inpatient and outpatient records of three patients who developed acute pancreatitis while being ...
Azar, Riad +3 more
core +4 more sources
Risperidone-induced erythema multiforme minor
Indian Journal of Psychological Medicine, 2017 Antipsychotic agents are known to cause adverse cutaneous reactions. These are supposedly rare with atypical antipsychotic agents. Adverse dermatologic reactions due to antipsychotic agent risperidone are rarely reported.
Shreyas Shrikant Pendharkar +3 more
doaj +1 more source
Altered brainstem responses to modafinil in schizophrenia: implications for adjunctive treatment of cognition. [PDF]
, 2018 Candidate pro-cognitive drugs for schizophrenia targeting several neurochemical systems have consistently failed to demonstrate robust efficacy. It remains untested whether concurrent antipsychotic medications exert pharmacodynamic interactions that ...
Carter, Cameron S +3 more
core +3 more sources
Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment. [PDF]
PLoS ONE, 2012 Psychiatric patients often require chronic treatment with antipsychotic drugs, and while rats are frequently used to study antipsychotic-induced metabolic adverse effects, long-term exposure has only partially mimicked the appetite-stimulating and weight-
Silje Skrede +6 more
doaj +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
ZIPRASIDONE: A NEW ATYPICAL ANTIPSYCHOTIC AGENT
Psychiatry and Clinical Psychopharmacology, 2021 Ziprasidone is a benzisothiazol piperazine derivative with a higher therapeutic efficacy and a favourable tolerability profile in the treatment of schizophrenia. Ziprasidone has a high 5-HT2 to D2 receptor binding ratio and also binds with high affinity
Artuner Deveci, Ayşen Esen Danacı
doaj
Symptomatic treatment of children with anti-NMDAR encephalitis. [PDF]
, 2016 AIM: We performed the first study on the perceived benefit and adverse effects of symptomatic management in children with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis.
Brilot, F +7 more
core +1 more source
Psychiatry and Clinical Psychopharmacology, 2018 Antipsychotic drugs are widely used in psychiatry and are associated with an increased risk of adverse effects such as venous thromboembolism. Olanzapine pamoate is a long-acting injectable form of the second-generation antipsychotic agent.
Serhat Tunç, Hamit Serdar Başbuğ
doaj +1 more source
Olanzapine-induced neuroleptic malignant syndrome
Indian Journal of Psychological Medicine, 2017 Neuroleptic malignant syndrome (NMS) is a life-threatening adverse effect usually seen with typical antipsychotic drugs. Rarely, NMS can occur with atypical antipsychotics also.
Pradeep Kumar Saha +3 more
doaj +1 more source